NCT01266083 2024-11-19WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)Sellas Life Sciences GroupPhase 2 Completed22 enrolled 8 charts
NCT03761914 2024-11-19Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced CancersSellas Life Sciences GroupPhase 1/2 Completed26 enrolled 14 charts
NCT00665002 2015-02-27Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid NeoplasmsH. Lee Moffitt Cancer Center and Research InstitutePhase NA Completed16 enrolled 8 charts